Compare Convatec Group Plc with Similar Stocks
Dashboard
1
High Debt Company with a Debt to Equity ratio (avg) at times
- Poor long term growth as Operating profit has grown by an annual rate 11.10% of over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
- The company has been able to generate a Return on Equity (avg) of 8.68% signifying low profitability per unit of shareholders funds
2
Poor long term growth as Operating profit has grown by an annual rate 11.10% of over the last 5 years
3
Positive results in Jun 25
4
With ROE of 16.89%, it has a very expensive valuation with a 4.31 Price to Book Value
5
Below par performance in long term as well as near term
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-9.72%
0%
-9.72%
6 Months
-7.04%
0%
-7.04%
1 Year
-15.63%
0%
-15.63%
2 Years
-23.89%
0%
-23.89%
3 Years
-4.03%
0%
-4.03%
4 Years
7.35%
0%
7.35%
5 Years
11.1%
0%
11.1%
Convatec Group Plc for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
4.62%
EBIT Growth (5y)
11.10%
EBIT to Interest (avg)
4.08
Debt to EBITDA (avg)
2.16
Net Debt to Equity (avg)
0.63
Sales to Capital Employed (avg)
0.73
Tax Ratio
22.55%
Dividend Payout Ratio
81.89%
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
9.70%
ROE (avg)
8.68%
Valuation key factors
Factor
Value
P/E Ratio
25
Industry P/E
Price to Book Value
4.31
EV to EBIT
19.00
EV to EBITDA
12.25
EV to Capital Employed
2.75
EV to Sales
3.17
PEG Ratio
1.07
Dividend Yield
NA
ROCE (Latest)
14.48%
ROE (Latest)
16.89%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
No Trend
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 2 Foreign Institutions (0.0%)
Strategic Entities with highest holding
Highest Public shareholder
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
1,850.70
1,791.50
3.30%
Operating Profit (PBDIT) excl Other Income
478.80
438.60
9.17%
Interest
53.10
64.90
-18.18%
Exceptional Items
-76.60
-15.60
-391.03%
Consolidate Net Profit
132.80
149.10
-10.93%
Operating Profit Margin (Excl OI)
166.90%
148.30%
1.86%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 3.30% vs 3.95% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -10.93% vs 42.27% in Dec 2024
About Convatec Group Plc 
Convatec Group Plc
Pharmaceuticals & Biotechnology
ConvaTec Group PLC is a United Kingdom-based medical product and technology company. The Company focuses on therapies for the management of chronic conditions, including products used for advanced chronic and acute wound care, ostomy care, continence and critical care and infusion devices used in the treatment of diabetes and other conditions. It operates across market franchises, such as Advanced Wound Care, which provides advanced wound dressings and skin care products; Ostomy Care, which provides devices, accessories and services for people with a stoma, resulting from colorectal cancer, inflammatory bowel disease, bladder cancer, obesity and other causes; Continence and Critical Care, which provides products for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida and other causes, and Infusion Devices, which provide disposable infusion sets.
Company Coordinates 
Company Details
Fl 7, 3 Forbury Place, 23 Forbury Road , READING None : RG1 3JH
Registrar Details






